Sponsor · clinical trials

University of Manitoba clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada, Spain, Norway, Brazil and Mexico registers with University of Manitoba as lead sponsor. Synced 14 Nov 2026

82Current trials

49Recruiting now

17Drugs in these trials

5Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 14 Nov 2026 · Editorial standards

At a glance

University of Manitoba is the lead sponsor of 82 current clinical trials in our Canada, Spain, Norway, Brazil and Mexico registers. 49 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are MPL-001, PluroGel and Standard dressing. The most-studied condition is Type 2 Diabetes.

ClinicalTrials.gov trials by status

Recruiting4960%
Not yet open1721%
Active, closed1316%
By invitation34%

Trials by phase

Not applicable5061%
Observational1518%
Phase 245%
Phase 345%
Phase 1/234%
Phase 122%
Early Phase 122%
Phase 422%

Clinical trials sponsored by University of Manitoba

82 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Investigating the Efficacy of an Augmented Virtual Reality Driving Simulator on Institutionalized Dementia Patients NCT06419257 · ClinicalTrials.gov ↗ · Advance Dementia	Not applicable	Recruiting	2024-01	Canada
CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes NCT05754567 · ClinicalTrials.gov ↗ · Neurocognitive Disorders	Observational	Recruiting	2023-09	Spain, Canada
Perioperative Virtual Reality Intervention for Pain and Anxiety During Vasectomies NCT07055178 · ClinicalTrials.gov ↗ · Vasectomy, Pain, Anxiety	Not applicable	Recruiting	2025-07	Canada
Development and Online Evaluation of an Online Course for Parasomnias NCT07361315 · ClinicalTrials.gov ↗ · Sleep Terror, Sleepwalking, Nightmare Disorder	Not applicable	Recruiting	2025-11	Canada
The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars NCT01619917 · ClinicalTrials.gov ↗ · Burn Scar	Not applicable	Recruiting	2012-11	Canada
The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars NCT01488240 · ClinicalTrials.gov ↗ · Burn Scar	Not applicable	Recruiting	2012-11	Canada
Acoustic OSA Prediction During Wakefulness and Monitoring During Sleep NCT04112927 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea	Observational	Recruiting	2021-10	Canada
A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries NCT05000983 · ClinicalTrials.gov ↗ · Burns Drugs: PluroGel, Standard dressing	Phase 1/2	Recruiting	2021-10	Canada
Technology in Play for Children With Physical Disabilities: the Dice Model of Play NCT06319430 · ClinicalTrials.gov ↗ · Disability Physical, Disabilities Mental	Not applicable	Recruiting	2025-02	Canada
Transcutaneous Spinal Electrical Stimulation to Improve Exercise Function After Spinal Cord Injury. NCT07692191 · ClinicalTrials.gov ↗ · Spinal Cord Injuries (SCI), Spinal Cord Injury, Spinal Injury	Not applicable	Recruiting	2024-06	Canada
Therapeutic Plasma Exchange in Septic Shock: A Pilot Study NCT05093075 · ClinicalTrials.gov ↗ · Septic Shock	Phase 2	Recruiting	2023-06	Canada
Type 1 Diabetes, Exercise and Mentoring Trial NCT06296992 · ClinicalTrials.gov ↗ · Type 1 Diabetes, Physical Activity	Not applicable	Recruiting	2025-02	Canada
Real World Evidence on the Use of Medical Cannabis in Pediatrics NCT05863910 · ClinicalTrials.gov ↗ · Cancer, Epilepsy, Neurodevelopmental Disorders Drug: Medical Cannabis	Observational	Recruiting	2023-11	Canada
CANnabinoids in Pediatric ONCology NCT05754840 · ClinicalTrials.gov ↗ · Childhood Cancer, Cancer Drugs: Cannabis oil, MPL-001	Phase 1/2	Recruiting	2025-07	Canada
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia NCT05848713 · Community-acquired Pneumonia Drug: Heparin	Phase 3	Recruiting	2023-10	Canada, Brazil, Mexico
Neuromodulation With Spinal Stimulation Methods NCT06272279 · ClinicalTrials.gov ↗ · Spinal Cord Injuries, Spinal Cord Injury at C5-C7 Level, Paraplegia, Spinal	Not applicable	Recruiting	2024-03	Canada
Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study) NCT02818192 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Proteinuria, Stress	Observational	Recruiting	2017-01	Canada
The Next Generation Longitudinal Birth Cohort Diabetes Study NCT04621396 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Gestational Diabetes Mellitus	Observational	Recruiting	2013-09	Canada
Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal NCT03954483 · ClinicalTrials.gov ↗ · Anxiety Drug: Buspirone	Not applicable	Recruiting	2023-10	Canada
Spinal Anesthesia For Enhanced Recovery After Liver Surgery NCT03715517 · ClinicalTrials.gov ↗ · Hepatectomy, Pain, Postoperative, Liver Neoplasms Drug: Morphine	Not applicable	Recruiting	2018-10	Canada
A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes NCT03695887 · ClinicalTrials.gov ↗ · Burns, Pain, Acute	Early Phase 1	Recruiting	2019-10	Canada
ICU Combined Assessment of Cardio-Respiratory Exercise NCT06193980 · ClinicalTrials.gov ↗ · ICU Acquired Weakness, Sepsis, Shock	Observational	Recruiting	2023-12	Canada
Pharmacogenomics-Supported Psychotropic Prescribing Trial NCT06929533 · ClinicalTrials.gov ↗ · Mental Disorder, Pharmacogenetics, Adverse Drug Reaction (ADR)	Not applicable	Recruiting	2025-07	Canada
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can) NCT04923984 · ClinicalTrials.gov ↗ · Subdural Hematoma	Not applicable	Recruiting	2021-05	Canada
Effects of Peripheral Repetitive Peripheral Magnetic Stimulation on Individuals With Elbow or Wrist Chronic Pain NCT07544914 · ClinicalTrials.gov ↗ · Tennis Elbow Syndrome, Golfer's Elbow, Carpal Tunnel Syndrome (CTS)	Not applicable	Recruiting	2026-07	Canada
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. NCT06298461 · ClinicalTrials.gov ↗ · Crohn Disease, Ulcerative Colitis	Phase 4	Recruiting	2024-07	Canada
Relaxing Virtual Reality Use and Blood Glucose Response to Food (ReViR) Study NCT07541794 · ClinicalTrials.gov ↗ · Post Prandial Blood Glucose, Feasibility Pilot Study	Not applicable	Recruiting	2026-09	Canada
Level Up! Adaptive Gaming for Children With Upper Limb Differences NCT05981664 · ClinicalTrials.gov ↗ · Upper Limb Amputation at the Wrist, Pediatric, Upper Limb Amputation	Not applicable	Recruiting	2024-01	Canada
Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Loneliness, and Mental Health Symptoms in Adults Ages 55+, Compared to Routine Community-Based Programming NCT07107906 · ClinicalTrials.gov ↗ · Loneliness, Social Isolation, Depression Disorders	Not applicable	Recruiting	2025-09	Canada
HD-tDCS to Modulate Connectivity NCT05959551 · ClinicalTrials.gov ↗ · Electricity; Effects	Not applicable	Recruiting	2023-07	Canada
Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities. NCT03595267 · ClinicalTrials.gov ↗ · Chronic Kidney Disease, Diabetes, Hypertension	Observational	Recruiting	2019-10	Canada
tDCS on Parkinson's Disease Cognition NCT03025334 · ClinicalTrials.gov ↗ · Parkinson Disease, Mild Cognitive Impairment	Not applicable	Recruiting	2017-03	Canada
Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial NCT05337033 · ClinicalTrials.gov ↗ · Chronic Migraine Drug: MPL-001	Phase 2	Recruiting	2024-10	Canada
A Multidisciplinary Investigation of Cardiovascular Benefits of Wild Rice NCT04119791 · ClinicalTrials.gov ↗ · Healthy Diet, Healthy	Not applicable	Recruiting	2024-11	Canada
Personalized B-fructan Diet in Inflammatory Bowel Disease Patients NCT05615779 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases, Ulcerative Colitis	Not applicable	Recruiting	2023-08	Canada
Investigating Different Frequencies of Transcranial Electrical Stimulations in Dementia Population NCT06547021 · ClinicalTrials.gov ↗ · Dementia	Not applicable	Recruiting	2024-09	Canada
Depth of Sedation and Its Impact on Cerebrovascular Reactivity in Acute Respiratory Distress Syndrome: a Pilot Analysis NCT05847634 · ClinicalTrials.gov ↗ · ARDS, Human	Observational	Recruiting	2024-11	Canada
Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression NCT06651801 · ClinicalTrials.gov ↗ · Mental Health Care, Anxiety and Depression, Pilot Study	Not applicable	Recruiting	2025-04	Canada
Dialectal Behaviour Therapy to Enhance Health Behaviour Change for Adolescents Living With Obesity (DIRECTION Trial) NCT05338944 · ClinicalTrials.gov ↗ · Prevention, Type2Diabetes	Not applicable	Recruiting	2023-01	Canada
Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury NCT01731444 · ClinicalTrials.gov ↗ · Blood Loss, Surgical Drug: Phenylephrine	Phase 1	Recruiting	2014-12	Canada
Non-Invasive Mapping of Cerebral Autoregulation Using Near Infrared Spectroscopy NCT05433129 · ClinicalTrials.gov ↗ · Cerebral Autoregulation Mapping	Not applicable	Recruiting	2023-07	Canada
Longitudinal Study to Investigate Different Transcranial Electrical Stimulation NCT06877312 · ClinicalTrials.gov ↗ · Dementia; Degenerative, Dementia Mixed	Not applicable	Recruiting	2024-10	Canada
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation NCT06763081 · ClinicalTrials.gov ↗ · Behavioral Activation, Major Depressive Disorder, Anxiety Disorders	Observational	Recruiting	2025-03	Canada
A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries NCT04893863 · ClinicalTrials.gov ↗ · Burns Drugs: PluroGel, Standard dressing	Phase 1/2	Recruiting	2021-10	Canada
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients NCT05726526 · ClinicalTrials.gov ↗ · Chronic Kidney Disease Stage 5, End Stage Renal Disease	Not applicable	Recruiting	2022-06	Canada
Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia NCT06599762 · ClinicalTrials.gov ↗ · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic/Myeloproliferative Neoplasm Drug: Tranexamic Acid	Phase 2	Recruiting	2025-09	Canada
Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients NCT07366515 · ClinicalTrials.gov ↗ · Oncologic Surgery	Not applicable	Recruiting	2026-04	Canada
Lemborexant Treatment of Insomnia Linked to Epilepsy NCT06262594 · ClinicalTrials.gov ↗ · Epilepsy, Sleep Drug: Lemborexant	Phase 3	Recruiting	2024-10	Canada
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS) NCT05985525 · ClinicalTrials.gov ↗ · Sepsis, Shock, Critical Illness	Observational	Recruiting	2022-05	Canada
Pilot Assessment of the Safety of a Combination of Curcumin, Omega-3, and Vitamin D Supplements in ACPA+ Individuals NCT06478290 · ClinicalTrials.gov ↗ · Healthy Participants	Not applicable	Not yet open	2025-10	Norway, Canada
Shockwave Therapy on Treating Erectile Dysfunction Following Nerve-sparing Radical Prostatectomy. NCT07819084 · ClinicalTrials.gov ↗ · Erectile Dysfunction	Not applicable	Not yet open	2026-12	Canada
Feasibility Testing of Plant-Based Supplemented Food Products Made With Manitoba Crop Ingredients for Weight Loss NCT06614543 · ClinicalTrials.gov ↗ · Weight Loss	Not applicable	Not yet open	2026-11	Canada
Designing and Implementing a Safety Net Surveillance Program for High Risk CKD NCT07724288 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases	Not applicable	Not yet open	2026-08	Canada
Platelet-Rich Fibrin for Preventing Osteoradionecrosis After Dental Extractions NCT07856875 · ClinicalTrials.gov ↗ · Osteoradionecrosis of the Jaw	Not applicable	Not yet open	2027-01	Canada
Implementing BEAM: A Scalable Digital Mental Health Program, for Families of Children Referred to Neurodevelopmental Services NCT07837791 · ClinicalTrials.gov ↗ · Depression and Anxiety Symptom, Anger, Parenting	Not applicable	Not yet open	2027-01	Canada
Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program NCT07926776 · ClinicalTrials.gov ↗ · ADHD, Maternal Mental Health, Dialectical Behavior Therapy	Not applicable	Not yet open	2026-11	Canada
Exploring the Genetics of Schizophrenia in Manitoba NCT07656870 · ClinicalTrials.gov ↗ · Schizophrenia, Healthy (Controls)	Observational	Not yet open	2026-08	Canada
Powdered Intrawound Vancomycin in Open Fractures Trial NCT06504992 · ClinicalTrials.gov ↗ · Open Fracture, Trauma, Infection, Surgical Site Drug: Vancomycin	Phase 4	Not yet open	2024-11	Canada
Co-designing Enhanced Models of Care for First Nations Children at Risk for Childhood-onset Type 2 Diabetes NCT07692321 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Gestational Diabetes Mellitus (GDM)	Observational	Not yet open	2026-08	Canada
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE. NCT07760675 · ClinicalTrials.gov ↗ · Cultural Safety, Medical Education, Cultural Competency	Not applicable	Not yet open	2026-09	Canada
Effectiveness of Zirconia Glaze Removal and Polish in the Treatment of Peri-implant Mucositis NCT06619158 · ClinicalTrials.gov ↗ · Peri-Implantitis and Peri-implant Mucositis	Not applicable	Not yet open	2024-11	Canada
Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period NCT07017439 · ClinicalTrials.gov ↗ · Benign Prostate Hypertrophy(BPH)	Phase 3	Not yet open	2025-08	Canada
Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) NCT07528417 · ClinicalTrials.gov ↗ · Myeldysplastic Syndrome (MDS), MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET), Acute Myeloid Leukemia Drug: Levofloxacin	Phase 2	Not yet open	2026-09	Canada
Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia NCT07017452 · ClinicalTrials.gov ↗ · Benign Prostate Hypertrophy(BPH) Drugs: Lorazepam, Methoxyflurane - Penthrox	Phase 3	Not yet open	2025-08	Canada
Recorded Parent/Caregiver Voice for Infants With Neonatal Opioid Withdrawal Syndrome NCT07864493 · ClinicalTrials.gov ↗ · Neonatal Opioid Withdrawal Syndrome, Prenatal Opioid Exposure, Opioid Withdrawal	Not applicable	Not yet open	2026-11	Canada
Feasibility of a Randomized Cluster Trial for Blood Pressure Targets in In-centre Hemodialysis Units NCT06695611 · ClinicalTrials.gov ↗ · Chronic Kidney Disease 5D	Not applicable	Not yet open	2025-02	Canada
Saskatoon Berry on Metabolism and Gut Microbiota in Healthy Subjects NCT04809688 · ClinicalTrials.gov ↗ · Nutritional and Metabolic Diseases	Not applicable	By invitation	2023-01	Canada
Virtual Kidney Check and Follow-up NCT06223750 · ClinicalTrials.gov ↗ · Kidney Disease, Chronic	Not applicable	By invitation	2024-11	Canada
Effects of Dried Whole Fruits on Metabolism in Diabetes NCT07354386 · ClinicalTrials.gov ↗ · Prediabetes, Type 2 Diabetes	Not applicable	By invitation	2026-04	Canada
Impact of Canadian Haskap Berry Powder on Hypertension and Acuity in Women's Health NCT06764121 · ClinicalTrials.gov ↗ · Hypertension, Alertness	Not applicable	Active, closed	2025-04	Canada
Management of CSDH With or Without EMMA- a Randomized Control Trial NCT04750200 · ClinicalTrials.gov ↗ · Chronic Subdural Hematoma	Not applicable	Active, closed	2021-08	Canada
Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes NCT05442840 · ClinicalTrials.gov ↗ · Diabetes Type 2	Not applicable	Active, closed	2022-07	Canada
Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer NCT05667298 · ClinicalTrials.gov ↗ · Esophageal Cancer	Phase 1	Active, closed	2023-03	Canada
Normal Brain Imaging Database for Brain Disorder Studies NCT03027869 · ClinicalTrials.gov ↗ · Healthy	Not applicable	Active, closed	2017-06	Canada
Impact of Diet and Exercise Activity on Pregnancy Outcomes NCT00486629 · ClinicalTrials.gov ↗ · Obesity, Gestational Diabetes, Type 2 Diabetes	Not applicable	Active, closed	2004-07	Canada
Promoting Positive Emotional Functioning in Police and Military Populations NCT06035562 · ClinicalTrials.gov ↗ · Anhedonia	Not applicable	Active, closed	2023-09	Canada
Advancing Family Wellbeing Through a Massive Open Online Intervention: The LightBEAM Program NCT07026838 · ClinicalTrials.gov ↗ · Depression, Anxiety, Anger, Parenting	Not applicable	Active, closed	2025-02	Canada
International Milk Composition (IMiC) Consortium NCT05119166 · ClinicalTrials.gov ↗ · Infant Growth, Maternal Health, Infant Nutrition Drug: Azithromycin	Observational	Active, closed	2019-11	Canada
Closing The Post Fracture Care Gap In Manitoba NCT00594789 · ClinicalTrials.gov ↗ · Osteoporosis	Not applicable	Active, closed	2008-06	Canada
Piloting a Healthy Aging Cohort in Manitoba NCT06100224 · ClinicalTrials.gov ↗ · Healthy Aging	Observational	Active, closed	2024-04	Canada
Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring NCT04972955 · ClinicalTrials.gov ↗ · Gestational Diabetes, Prediabetes; Complicating Pregnancy, Type 2 Diabetes	Observational	Active, closed	2023-07	Canada
Vulvovaginal Candidiasis in Canadian Females NCT04930107 · ClinicalTrials.gov ↗ · Candidiasis, Vulvovaginal Drug: Fluconazole	Early Phase 1	Active, closed	2021-12	Canada

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in University of Manitoba trials

17 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

MPL-0012 PluroGel2 Standard dressing2 Azithromycin1 Buspirone1 Cannabis oil1 Fluconazole1 Heparin1 Lemborexant1 Levofloxacin1 Lorazepam1 Medical Cannabis1 Methoxyflurane - Penthrox1 Morphine1 Phenylephrine1 Tranexamic Acid1 Vancomycin1

Conditions in University of Manitoba trials

145 conditions

Type 2 Diabetes6 Anxiety3Burns3Burn Scar2Hypertension2 Healthy2Gestational Diabetes2Cancer2 Epilepsy2Anger2Parenting2Sepsis2Shock2Critical Illness2 Ulcerative Colitis2Benign Prostate Hypertrophy(BPH)2Acute Myeloid Leukemia2Neurocognitive Disorders1Healthy Participants1Advance Dementia1Vasectomy1Pain1 Virtual Reality1Sleep Terror1

By trial register

Register	Trials	Recruiting
Clinical trials in Canada	82	49
Clinical trials in Spain	1	1
Clinical trials in Norway	1	0
Clinical trials in Brazil	1	1
Clinical trials in Mexico	1	1

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Type 2 Diabetes

Sponsor	Trials
Hangzhou Zhongmei Huadong Pharmaceutical	5
Steno Diabetes Center Copenhagen	5
Fujian Shengdi Pharmaceutical	4
German Institute of Human Nutrition	4
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	3
Odense University Hospital	3
University of Toronto	3
LMC Diabetes & Endocrinology	3
Seoul National University Bundang Hospital	3
DexCom	2

Sponsors with the most current trials registered for this condition.

Questions about University of Manitoba trials

How many clinical trials does University of Manitoba sponsor?

University of Manitoba is the lead sponsor of 82 current trials on ClinicalTrials.gov in our Canada, Spain, Norway, Brazil and Mexico registers, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are University of Manitoba trials recruiting?

Yes. 49 of its 82 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of Manitoba testing?

Its current trials name 17 drugs and biologicals as interventions. The most frequent are MPL-001 (2), PluroGel (2), Standard dressing (2), Azithromycin (1) and Buspirone (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.